101 related articles for article (PubMed ID: 26862950)
1. Downexpression of Matriptase-2 Correlates With Tumor Progression and Clinical Prognosis in Oral Squamous-Cell Carcinoma.
Cheng MF; Lin LH; Huang MS; Lee HS; Ji DD; Lin CS; Hsia KT
Appl Immunohistochem Mol Morphol; 2017 Aug; 25(7):481-488. PubMed ID: 26862950
[TBL] [Abstract][Full Text] [Related]
2. Expression of matriptase correlates with tumour progression and clinical prognosis in oral squamous cell carcinoma.
Cheng MF; Huang MS; Lin CS; Lin LH; Lee HS; Jiang JC; Hsia KT
Histopathology; 2014 Jul; 65(1):24-34. PubMed ID: 24382204
[TBL] [Abstract][Full Text] [Related]
3. Surrogate Prognostic Biomarkers in OSCC: The Paradigm of PA28γ Overexpression.
Kontos CK
EBioMedicine; 2015 Aug; 2(8):784-5. PubMed ID: 26425675
[No Abstract] [Full Text] [Related]
4. Deregulated matriptase activity in oral squamous cell carcinoma promotes the infiltration of cancer-associated fibroblasts by paracrine activation of protease-activated receptor 2.
Kanemaru A; Yamamoto K; Kawaguchi M; Fukushima T; Lin CY; Johnson MD; Camerer E; Kataoka H
Int J Cancer; 2017 Jan; 140(1):130-141. PubMed ID: 27615543
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of BST2 is associated with nodal metastasis and poorer prognosis in oral cavity cancer.
Fang KH; Kao HK; Chi LM; Liang Y; Liu SC; Hseuh C; Liao CT; Yen TC; Yu JS; Chang KP
Laryngoscope; 2014 Sep; 124(9):E354-60. PubMed ID: 24706327
[TBL] [Abstract][Full Text] [Related]
6. Upregulated expression of ADAM12 is associated with progression of oral squamous cell carcinoma.
Uehara E; Shiiba M; Shinozuka K; Saito K; Kouzu Y; Koike H; Kasamatsu A; Sakamoto Y; Ogawara K; Uzawa K; Tanzawa H
Int J Oncol; 2012 May; 40(5):1414-22. PubMed ID: 22267082
[TBL] [Abstract][Full Text] [Related]
7. Co-Expression of TWIST1 and ZEB2 in Oral Squamous Cell Carcinoma Is Associated with Poor Survival.
Kong YH; Syed Zanaruddin SN; Lau SH; Ramanathan A; Kallarakkal TG; Vincent-Chong VK; Wan Mustafa WM; Abraham MT; Abdul Rahman ZA; Zain RB; Cheong SC
PLoS One; 2015; 10(7):e0134045. PubMed ID: 26214683
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of matriptase correlates with poor prognosis in esophageal squamous cell carcinoma.
Ha SY; Kim KY; Lee NK; Kim MG; Kim SH
Virchows Arch; 2014 Jan; 464(1):19-27. PubMed ID: 24248283
[TBL] [Abstract][Full Text] [Related]
9. Increased placenta growth factor mRNA level is significantly associated with progression, recurrence and poor prognosis of oral squamous cell carcinoma.
Cheng SJ; Cheng SL; Lee JJ; Chen HM; Chang HH; Kok SH; Chiang ML; Kuo MY
J Formos Med Assoc; 2013 May; 112(5):253-8. PubMed ID: 23660220
[TBL] [Abstract][Full Text] [Related]
10. Cathepsin expression in oral squamous cell carcinoma: relationship with clinicopathologic factors.
Kawasaki G; Kato Y; Mizuno A
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2002 Apr; 93(4):446-54. PubMed ID: 12029284
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
Su L; Wang Y; Xiao M; Lin Y; Yu L
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995
[TBL] [Abstract][Full Text] [Related]
12. ASC contributes to metastasis of oral cavity squamous cell carcinoma.
Wu CS; Chang KP; OuYang CN; Kao HK; Hsueh C; Chen LC; Cheng HY; Liang Y; Liou W; Liang CL; Chang YS
Oncotarget; 2016 Aug; 7(31):50074-50085. PubMed ID: 27367024
[TBL] [Abstract][Full Text] [Related]
13. Aurora B expression as a prognostic indicator and possible therapeutic target in oral squamous cell carcinoma.
Pannone G; Hindi SA; Santoro A; Sanguedolce F; Rubini C; Cincione RI; De Maria S; Tortorella S; Rocchetti R; Cagiano S; Pedicillo C; Serpico R; Lo Muzio L; Bufo P
Int J Immunopathol Pharmacol; 2011; 24(1):79-88. PubMed ID: 21496390
[TBL] [Abstract][Full Text] [Related]
14. Immunoscoring of epidermal growth factor receptor expression in recurrent cases of oral squamous cell carcinoma.
Mehta A; Chowdhary M; Sinha R
J Oral Pathol Med; 2015 Nov; 44(10):818-22. PubMed ID: 25581523
[TBL] [Abstract][Full Text] [Related]
15. Low miR-143/miR-145 Cluster Levels Induce Activin A Overexpression in Oral Squamous Cell Carcinomas, Which Contributes to Poor Prognosis.
Bufalino A; Cervigne NK; de Oliveira CE; Fonseca FP; Rodrigues PC; Macedo CC; Sobral LM; Miguel MC; Lopes MA; Paes Leme AF; Lambert DW; Salo TA; Kowalski LP; Graner E; Coletta RD
PLoS One; 2015; 10(8):e0136599. PubMed ID: 26317418
[TBL] [Abstract][Full Text] [Related]
16. Tripeptidyl peptidase II in human oral squamous cell carcinoma.
Usukura K; Kasamatsu A; Okamoto A; Kouzu Y; Higo M; Koike H; Sakamoto Y; Ogawara K; Shiiba M; Tanzawa H; Uzawa K
J Cancer Res Clin Oncol; 2013 Jan; 139(1):123-30. PubMed ID: 22986808
[TBL] [Abstract][Full Text] [Related]
17. Nicotinamide N-methyltransferase upregulation inversely correlates with lymph node metastasis in oral squamous cell carcinoma.
Sartini D; Santarelli A; Rossi V; Goteri G; Rubini C; Ciavarella D; Lo Muzio L; Emanuelli M
Mol Med; 2007; 13(7-8):415-21. PubMed ID: 17622326
[TBL] [Abstract][Full Text] [Related]
18. EMMPRIN expression in oral squamous cell carcinomas: correlation with tumor proliferation and patient survival.
Monteiro LS; Delgado ML; Ricardo S; Garcez F; do Amaral B; Pacheco JJ; Lopes C; Bousbaa H
Biomed Res Int; 2014; 2014():905680. PubMed ID: 24967412
[TBL] [Abstract][Full Text] [Related]
19. CMTM3 inhibits cell growth and migration and predicts favorable survival in oral squamous cell carcinoma.
Zhang H; Zhang J; Nan X; Li X; Qu J; Hong Y; Sun L; Chen Y; Li T
Tumour Biol; 2015 Sep; 36(10):7849-58. PubMed ID: 25946973
[TBL] [Abstract][Full Text] [Related]
20. High HMGA2 Expression Correlates with Reduced Recurrence-free Survival and Poor Overall Survival in Oral Squamous Cell Carcinoma.
Fang CY; Liew PL; Chen CL; Lin YH; Fang CL; Chen WY
Anticancer Res; 2017 Apr; 37(4):1891-1899. PubMed ID: 28373457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
